Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage
Status:
Completed
Trial end date:
2020-09-23
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to explore the efficacy of small doses of oral
glibenclamide on brain edema after acute primary intracerebral hemorrhage (ICH), and
improving the prognosis of patients.